Cargando…
EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network
Autores principales: | Moll, K, Hobbi, S, Zhou, CK, Fingar, K, Burrell, T, Hernandez-Medina, V, Alawar, N, Anderson, SA, Wong, HL, Obidi, J, Shoaibi, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232824/ http://dx.doi.org/10.1016/j.jval.2022.04.905 |
Ejemplares similares
-
Assessment of performance characteristics of COVID-19 ICD-10-CM diagnosis code U07.1 using SARS-CoV-2 nucleic acid amplification test results
por: Moll, Keran, et al.
Publicado: (2022) -
Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database
por: Moll, Keran, et al.
Publicado: (2021) -
Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database
por: Saunders-Hastings, Patrick, et al.
Publicado: (2021) -
EPH61 Uptake of the Post COVID-19 Condition ICD-10-CM Diagnosis Code By Social Factors
por: Lee, A.D., et al.
Publicado: (2023) -
Characterization of test positivity among patients with coronavirus disease 2019 (COVID-19) in three electronic health records databases, February–November 2020
por: Saunders-Hastings, Patrick, et al.
Publicado: (2022)